Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Abroad (travel likely)RecruitingPHASE2

Conditions

Aplastic Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Saint Louis hospital, Paris, France, France
Contact: Study coordinator (Régis Peffault de La Tour, MD PhD) · +33142385073
CHU Amiens, Amiens, France
Contact: Study coordinator (Magalie Joris) · joris.magalie@chu-amiens.fr · +33 3 22 45 54 23
CHU Angers, Angers, France
Contact: Study coordinator (Sylvie François) · syfrancois@chu-angers.fr · +33 2 41 35 44 82
CHU Besançon, Besançon, France
Contact: Study coordinator (Etienne Daguindau) · edaguindau@chu-besancon.fr · +33370632285
CHU Bordeaux, Bordeaux, France
Contact: Study coordinator (Edouard Forcade) · edouard.forcade@chu-bordeaux.fr · +33 5 57 65 65 11
CHU Caen, Caen, France
Contact: Study coordinator (Sylvain Chantepie) · Chantepie-s@chu-caen.fr · +33231272073
HNIA Percy, Clamart, France
Contact: Study coordinator (Johanna Konopacki) · johanna.konopacki@intradef.gouv.fr · +33 1 41 46 63 03
Hôpital d'Estaing, Clermont-Ferrand, France
Contact: Study coordinator (Aurélie Ravinet) · aravinet@chu-clermontferrant.fr · +33 4 73 75 00 65
Hôpital Henri Mondor AP-HP, Créteil, France
Contact: Study coordinator (Sébastien Maury) · sebastien.maury@aphp.fr · +33 1 49 81 45 26
CHU Grenoble Alpes, Grenoble, France
Contact: Study coordinator (Claude-Eric Bulabois) · cebulabois@chu-grenoble.fr · +33 4 76 76 92 09
CHU Lille, Lille, France
Contact: Study coordinator (Micha Srour) · Micha.SROUR@chu-lille.fr
Contact: Study coordinator (Micha Srour) · Micha.SROUR@chu-lille.fr · +33 3 20 44 42 85
CHU Limoges, Limoges, France
Contact: Study coordinator (Pedro de Lima Prata) · Pedro.PRATA@chu-limoges.fr · +33 5 55 05 88 67
CHU Lyon Sud, Lyon, France
Contact: Study coordinator (Vincent Alcazer) · vincent.alcazer@chu-lyon.fr · +33 4 78 86 22 59
Institut Paoli Calmettes, Marseille, France
Contact: Study coordinator (Raynier Devillier) · DEVILLIERR@ipc.unicancer.fr · +33 4 91 22 33 33
CHU Montpellier, Montpellier, France
Contact: Study coordinator (Patrice Ceballos) · p-ceballos@chu-montpellier.fr · +33 4 67 33 32 68
CHRU Nancy, Nancy, France
Contact: Study coordinator (Simona Pagliuca) · s.pagliuca@chru-nancy.fr · +33383155259
CHU Nantes, Nantes, France
Contact: Study coordinator (Alice Garnier) · alice.garnier@chu-nantes.fr · +33 2 40 08 42 28
CHU Nice, Nice, France
Contact: Study coordinator (Michael Loschi) · loschi.m@chu-nice.fr · +33 4 92 03 52 11
Hopital Necker - APHP, Paris, France
Contact: Study coordinator (Felipe Suarez) · felipe.suarez@aphp.fr · +331 44 49 51 88
Hôpital La Pitié Salpêtrière AP-HP, Paris, France
Contact: Study coordinator (Stéphanie Nguyen-Quoc) · stephanie.nguyen-quoc@aphp.fr · +33 1 42 17 61 84
CHU Poitiers, Poitiers, France
Contact: Study coordinator (Natacha Maillard) · natacha.maillard@chu-poiters.fr · +33 5 16 60 43 29
CHU Rennes, Rennes, France
Contact: Study coordinator (Jean-Baptiste Mear) · jean-baptiste.mear@chu-rennes.fr · +33299284321
Henri Becquerel, Rouen, France
Contact: Study coordinator (Anne-Lise Menard) · anne-lise.menard@chb-unicancer.fr · +33 2.32.08.24.98
CHU Saint Etienne, Saint-Etienne, France
Contact: Study coordinator (Jérôme Cornillon) · Jerome.Cornillon@chu-st-etienne.fr · +334 77 82 24 55
CHU Strasbourg, Strasbourg, France
Contact: Study coordinator (Bruno Lioure) · bruno.lioure@chru-strasbourg.fr · +33 3 68 76 74 03
CHU Toulouse, Toulouse, France
Contact: Study coordinator (Anne Huynh) · huynh.anne@iuct-oncopole.fr · +33 5 31 15 63 31

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Severe Aplastic Anemia · Hypo-Plastic MDS · Myelodysplastic Syndrome (MDS)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Severe Aplastic Anemia (SAA) · Hypo-Plastic Myelodysplastic Syndrome (MDS) · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

Hemoglobinopathy (Disorder) · Severe Aplastic Anemia · Bone Marrow Failure Syndrome

Abroad (travel likely)RecruitingPHASE2

St. Petersburg, United States

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Severe Aplastic Anemia

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Atlanta, United States